Worth Venture Partners, LLC Axsome Therapeutics, Inc. Transaction History

Worth Venture Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$2.63 - $16.34 $90,598 - $562,880	-34,448 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$2.0 - $4.15 $11,104 - $23,040	-5,552 Reduced 13.88%	34,448 $96,000
Q3 2018 Nov 15, 2018	BUY	$2.3 - $3.55 $92,000 - $142,000	40,000 New	40,000 $138,000

327

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.45B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.